The differential expression patterns of the B7H4 and PD-L1/PD-1 axis are relevant to checkpoint blockade therapy, as identifying which pathway is active in a given tumour may have predictive value for the efficacy of ICI therapy. Here, VTCN1 is linked to neoplasm.